BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15026875)

  • 21. Efficacy and safety of long-term losartan therapy demonstrated by a prospective observational study in Japanese patients with hypertension: The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study.
    Naritomi H; Fujita T; Ito S; Ogihara T; Shimada K; Shimamoto K; Tanaka H; Yoshiike N
    Hypertens Res; 2008 Feb; 31(2):295-304. PubMed ID: 18360050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of losartan on ambulatory short-term blood pressure variability and cardiovascular remodeling in hypertensive patients on hemodialysis.
    Mitsuhashi H; Tamura K; Yamauchi J; Ozawa M; Yanagi M; Dejima T; Wakui H; Masuda S; Azuma K; Kanaoka T; Ohsawa M; Maeda A; Tsurumi-Ikeya Y; Okano Y; Ishigami T; Toya Y; Tokita Y; Ohnishi T; Umemura S
    Atherosclerosis; 2009 Nov; 207(1):186-90. PubMed ID: 19423110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).
    Ambrosioni E; Bombelli M; Cerasola G; Cipollone F; Ferri C; Grazioli I; Leprotti C; Mancia G; Melzi G; Mugellini A; Mulè G; Palasciano G; Salvetti A; Trimarco B
    Adv Ther; 2010 Jun; 27(6):365-80. PubMed ID: 20556561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of long-term antihypertensive therapy with losartan on blood pressure and cognitive function in patients with essential hypertension and other cerebrovascular risk factors (AWARE observational study)].
    Schrader J; Lüders S; Diener HC; Haller H; Schmieder RE; Wahle K; Smolka W; Jung C; Bestehorn K
    Med Klin (Munich); 2008 Jul; 103(7):491-9. PubMed ID: 18604484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe malaria in Cameroonian children: correlation between plasma levels of three soluble inducible adhesion molecules and TNF-alpha.
    Tchinda VH; Tadem AD; Tako EA; Tene G; Fogako J; Nyonglema P; Sama G; Zhou A; Leke RG
    Acta Trop; 2007 Apr; 102(1):20-8. PubMed ID: 17397790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
    Weiss RJ; Stapff M; Lin Y
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors.
    Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Horký K; Aschermann M
    J Hum Hypertens; 2002 Aug; 16(8):557-62. PubMed ID: 12149661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating levels of endothelin-1 during acute hyperinsulinemia in patients with essential hypertension treated with type 1 angiotensin receptor antagonist or placebo.
    Seljeflot I; Moan A; Aspelin T; Tønnessen T; Kjeldsen SE; Arnesen H
    Metabolism; 1998 Mar; 47(3):292-6. PubMed ID: 9500565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The safety of long-term administration of losartan in current clinical practice: a non-intervention NCT-CZ 14/04/LOZ study].
    Krupicka J; Ceypová K; Kristenová P; Hauser T
    Vnitr Lek; 2008 Nov; 54(11):1031-8. PubMed ID: 19069675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the angiotensin receptor antagonist losartan on the response of the left main coronary artery to cold pressor test in patients with essential hypertension as assessed by echocardiography.
    Deng YB; Wang DW; Li CL; Yang HY
    Can J Cardiol; 2002 Apr; 18(4):389-96. PubMed ID: 11992132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of platelet aggregability by losartan in essential hypertension.
    Levy PJ; Yunis C; Owen J; Brosnihan KB; Smith R; Ferrario CM
    Am J Cardiol; 2000 Dec; 86(11):1188-92. PubMed ID: 11090789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The antihypertensive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring. Canadian Cozaar Hyzaar Amlodipine Trial Study Group.
    Wilson TW; Lacourcière Y; Barnes CC
    CMAJ; 1998 Sep; 159(5):469-76. PubMed ID: 9757170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Losartan attenuates the antimigratory effect of diclofenac in spontaneously hypertensive rats.
    Martinez LL; Oliveira MA; Miguel AS; Rastelli VM; Cruz JW; Tostes RC; Carvalho MH; Nigro D; Fortes ZB
    J Cardiovasc Pharmacol; 2005 Aug; 46(2):190-9. PubMed ID: 16044031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of celecoxib on soluble intercellular adhesion molecule-1 and soluble e-cadherin concentrations in human colon cancer cell line cultures exposed to phytic acid and TNF-alpha.
    Parfiniewicz B; Pendzich J; Gruchlik A; Hollek A; Weglarz L
    Acta Pol Pharm; 2012; 69(6):1283-90. PubMed ID: 23285691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Control of home blood pressure with an amlodipine- or losartan-based regimen and progression of carotid artery intima-media thickness in hypertensive patients: the HOSP substudy.
    Ohta Y; Kawano Y; Iwashima Y; Hayashi S; Yoshihara F; Matayoshi T; Takiuchi S; Kamide K; Nakamura S; Horio T
    Clin Exp Hypertens; 2013; 35(4):279-84. PubMed ID: 23530977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of angiotensin II type 1 receptor in the regulation of cellular adhesion molecules in atherosclerosis.
    Prasad A; Koh KK; Schenke WH; Mincemoyer R; Csako G; Fleischer TA; Brown M; Selvaggi TA; Quyyumi AA
    Am Heart J; 2001 Aug; 142(2):248-53. PubMed ID: 11479463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of the renin-angiotensin system does not reduce platelet activity at rest or during stress in hypertension.
    Schwieler JH; Kahan T; Wallén NH; Nussberger J; Hjemdahl P
    J Hypertens; 2013 Aug; 31(8):1676-82. PubMed ID: 23625113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased levels of soluble TNF-alpha receptors and cellular adhesion molecules in patients undergoing bioincompatible hemodialysis.
    Rysz J; Majewska E; Stolarek RA; Banach M; Ciałkowska-Rysz A; Baj Z
    Am J Nephrol; 2006; 26(5):437-44. PubMed ID: 16988495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of TNF-alpha on concentration of soluble adhesion molecules in cultures of HT-29 cells exposed to inositol hexaphosphate.
    Parfiniewicz B; Pendzich J; Kapral M; Bednarek I; Weglarz L
    Acta Pol Pharm; 2012; 69(6):1291-7. PubMed ID: 23285692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Serum tumor necrosis factor alpha (TNF-alpha) concentration correlates with soluble adhesion molecules and vascular endothelial growth factor (VEGF) in rheumatoid arthritis].
    Klimiuk PA; Sierakowski S; Fiedorczyk M; Chwiećko J
    Przegl Lek; 2004; 61(2):86-9. PubMed ID: 15230147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.